Abstract
Platelet shape change (PSC) is an early phase of platelet activation that precedes platelet aggregation. This phase of platelet activation is essentially aspirin resistant. PSC was monitored, by measuring the median platelet volume (MPV) using a high resolution channelyser. Angiotensin (Ang) II, added in vitro, caused a significant (P = 0.004) increase in MPV in platelet rich plasma prepared from healthy subjects (n = 14). This increase in MPV was marked (>0.40 fl) in 57% (n = 8) of these subjects and was significantly inhibited (P < 0.008) by losartan (a selective ang ii antagonist) at concentrations similar to those achieved in the circulation during treatment. ang ii also significantly enhanced sub-maximal psc induced by adp and serotonin in all subjects tested. losartan significantly (n = 9; P < 0.001) inhibited u46619 (a thromboxane a2 analogue)-induced PSC. These findings suggest that losartan, in addition to its blood pressure lowering action, has antiplatelet activity. This property may be clinically relevant because of the increased risk of vascular events in hypertensive patients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jagroop, I., Mikhailidis, D. Angiotensin II can induce and potentiate shape change in human platelets: effect of losartan. J Hum Hypertens 14, 581–585 (2000). https://doi.org/10.1038/sj.jhh.1001102
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.jhh.1001102
Keywords
This article is cited by
-
Lung histopathological findings in COVID-19 disease – a systematic review
Infectious Agents and Cancer (2021)
-
Effect of new oral anticoagulants on platelet indices in non-valvular atrial fibrillation patients
Herz (2021)
-
Are losartan and imatinib effective against SARS-CoV2 pathogenesis? A pathophysiologic-based in silico study
In Silico Pharmacology (2020)
-
Prognostic value of rising mean platelet volume during hospitalization in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention
BMC Cardiovascular Disorders (2018)
-
Relationship between mean platelet volume and metabolic syndrome in Chinese patients
Scientific Reports (2018)